Jtorrence

20 PHARMAS and one signs term sheet.
One has interest enough to move on B.

The others see the definite interest and so could move in also.

B works and many know that.

Echo20

Rdunn88

You stated you have a good sized investment in IPIX. PLAY LIKE IT.

PLAY FOR IPIX AND THE INVESTORS.

Echo20

Rdunn88


Way too low.

Look more towards $12 to $20 per share.

This has been going in a long time.

Echo20

Bradford brothers

Competition bidding now.

Value showing up. The early bird gets the formula.

Echo20

NickAudenNY


The Company signed a non-binding term sheet in August 2018 with a global pharmaceutical company for the licensing/rights to Brilacidin for treating oral mucositis and inflammatory bowel diseases. Initial payments, milestone payments and royalties are being negotiated in accordance with the non-binding term sheet. The pharmaceutical company is now engaged in further due diligence. Management can offer no assurances that the parties will enter into a binding definitive agreement.
____________________________

I hope they do not look on this board for info

Echo20

Mxdud

There is a lock in the data this time.

Echo20

Could this be the start of bidding wars?


Echo20

Go up IPIX.

I hope Leo gets a good price for the formulas and IPIX.

Deal well Leo.

Echo30

The Dane

Thanks.

Hardball.

Echo20

Bradford brothers

A HARDBALL SQUEEZE.

Echo20

Dane

Is the term sheet with one pharma or more?

License?

Echo20

Rdunn88

Maybe Leo has to wait for the lock also.
Lots of information without actual clinical trial facts going on.

Echo20

Scottsmith

Do you state publicly that the data lock is still on or off?

Echo20

Biodoc

Is this statement true:

Quote:The Company signed a non-binding term sheet in August 2018 with a global pharmaceutical company for the licensing/rights to Brilacidin for treating oral mucositis and inflammatory bowel diseases

If true this is a great motion.

Echo20

Buy low.

Echo20

This could be companies playing hard ball.
Low price intended.

But low.

Echo20

DaubersUP

Sounds good. Thanks for posting.
That is on B? With two manufacturers ready to go.

Echo20

BooDog

If the lock is still on the P a results this can all be emotional reactions.

Echo20

Jtorrence

Maybe even Serepta Pharmaceuticals will buy IPIX even with no marketed products.
Serepta is up to $147.00 per share now.

Echo20

BooDog

Even with a volume of over 600,000 shares that is not a lot of the total shares if IPIX.

EMOTIONAL RESPONSES.

Echo20

Maxdud

The LOCK IS STILL ON and the SEC could be looking in. 20 pharmas could also be monitoring the P results. No one wants to get information last or second.

Echo20

Rdunn88

Even the 10k states IPIX is waiting for results on P. Lock is still on.

Echo20

Maxdud
You do not want to pull Leo's bad past actions by negative pressures now.
He gave a lot of relatives stock in IPIX and he would not want that to go bad.

Echo20

Scottsmith

The lock is still on.

That has to come off.

Echo20

bradfordbrothers

The day-long conference, hosted by the Crohn’s & Colitis Foundation and sponsored, in part, by Celgene Corporation, will be held on November 13, 2018, at the New York Academy of Medicine located in New York, NY.

This conference is to be held on November 13, 2018 and so will not help the September 30th deadline.

Leo still has a lot to get done by September 30th.

Go IPIX stock Leo.

Echo20

IPIX

From Google News:

While the funding frenzy has left companies that need capital for ambitious research flush, some observers are uneasy. Many of the newly public firms have no approved drugs and no near-term prospect for making any money. Several companies that sold shares recently — including Translate Bio and Neon Therapeutics — are trading below their IPO price.

The prospects for getting out of private biotech investments are also increasingly unclear. Large drugmakers that typically acquire young companies to replenish their own pipelines have been complaining more loudly about lofty valuations. Merck & Co. Chief Executive Ken Frazier said on a conference call in July that small biotechs have access to ample capital and “the deals that are getting done are being done at very high prices and premiums.

Echo20”

FarmaZutical

Great post but LEO and IPIX still have a lock on the P information and that has to come off for anyone to know the P results.

The B potentials will show up at the SHow.

Echo20

kfcyahoo.com

Maybe he has to wait to get the P information like anyone else.

Once the lock is off.

It looks bad but the lock is still on.

Echo20

Bradford brothers

To not work on a religious holiday shows confidence.

Maybe Leo has knowledge that makes him confidant now with the timelines and P results and 20 PHARMAS lurking around. Plus the SEC of they are looking for fraudsters in small stocks.

Echo20

Scottsmith

Maybe Leo has to wait also.
Maybe he has to get real results to get real potentials for IPIX.

Clinical trials cost a little of time and money.

Echo20

Rdunn88

A current need would be better but do not knock the needs of the potentials. This is a small innovative company not a full pharma with tons of money and lab space.

Echo20

Rdunn88

With 2 manufacturers ready the show will have more potentials ready.

The prior interest plus 2 manufacturers could be enough to make a hit with B.

B works and that has been proven in clinical trials. Expensive clinical trials.

Echo20

Rdunn88

We have to wait for the show to find out.

Echo20

Rdunn88

They are ready to make enough B for every purpose possible. Trials and anything else.


Good point though.

Echo20

Rdunn88

The show could click with B and 2 manufacturers ready to go.

Echo20

TIAB

Jumping on a downtrend.

easy going.

Echo20

georgejji

This and your other posts on IPIX plus the post by the Bunny that was positive show signs for great improvements on IPIX.
RDunn88 posts positive also.

Echo20

Kfcyahoo

I hope George wins.
With the Bunny's positive post this looks better. Go George.

Echo20

Bunny

That is very positive Bunny!

Possible potentials.

Echo20

Kfcyahoo

Ipix has many reasons why the stock would go up now.

Echo20